Home > Insider Trading > Filing (0001209191-17-053727)

Filing Details

Accession Number:: 0001209191-17-053727
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-09-22 16:42:21
Reporting Period:: 2017-09-20

Accepted Time:: 2017-09-22 16:42:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1339469	Chiasma Inc	CHMA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1586687	Scott Minick	C/O Chiasma, Inc. 275 Wyman Street, Suite 250 Waltham MA 02451		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-09-20	15,000	$2.38	49,220	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2017-09-21	10,000	$2.36	59,220	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	62,531	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $2.3736 to $2.3871. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
The Form 4 filed on July 22, 2015 (the "July 2015 Form 4") incorrectly reported the aggregate shares held by the Reporting Person, directly and indirectly, in the second row of Column 5. As of July 21, 2015, the Reporting Person beneficially owned 62,531 shares of common stock of the Issuer directly and 34,220 shares of common stock of the Issuer, including a warrant to purchase 6,844 shares of common stock of the Issuer, indirectly through the Minick Family Trust ("MFT"). This Form 4 reflects the transactions reported herein and corrects the total shares directly and indirectly held in Column 5.
The securities are directly held by MFT. The Reporting Person is the co-trustee of MFT and disclaims beneficial ownership of all the shares except to the extent of his pecuniary interest, if any, therein.
This transaction was executed in multiple trades at prices ranging from $2.3354 to $2.3783. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.